SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-035453
Filing Date
2008-06-05
Accepted
2008-06-05 17:07:38
Documents
1
Period of Report
2008-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3814
  Complete submission text file 0001209191-08-035453.txt   5840
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address C/O GENAERA CORP 5110 CAMPUS DRIVE PLYMOUTH MEETING PA 19462
Business Address C/O GENAERA CORP 5110 CAMPUS DR PLYMOUTH MEETING PA 19462 610 941 4020
WYNGAARDEN JAMES B (Reporting) CIK: 0001022940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 08883713